Development and Validation of an Anxiety Disorder Prediction Model for Premature Ejaculation Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

700 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-25

Study Completion Date

2026-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

Premature ejaculation (PE) is a common sexual dysfunction that can significantly impact the quality of life and psychological well-being of affected individuals. Anxiety disorders, often comorbid with PE, exacerbate symptoms and complicate treatment outcomes. There is a critical need for a reliable prediction model to identify patients at risk of developing anxiety disorders associated with PE.

Objective:

The primary aim of this study is to develop and validate a predictive model that accurately identifies premature ejaculation patients who are at high risk of developing anxiety disorders. The model will be designed to facilitate early intervention strategies and improve patient outcomes.

Methods:

This prospective observational study will enroll male patients diagnosed with PE from multiple clinical centers. Participants will undergo comprehensive assessments including validated questionnaires, clinical interviews, and medical history reviews to collect baseline data on potential predictors of anxiety disorders. Machine learning algorithms will be utilized to analyze the collected data and derive a predictive model. External validation will be conducted using a separate cohort of patients not involved in the initial model development phase.

Outcome Measures:

The primary outcome measure will be the accuracy of the predictive model in identifying patients who subsequently develop anxiety disorders within a predefined follow-up period. Secondary outcomes include evaluating the model's sensitivity, specificity, positive predictive value, and negative predictive value.

Significance:

Successful development and validation of this prediction model could lead to improved patient care through targeted interventions and personalized treatment plans for those at risk of anxiety disorders related to PE. This research may also contribute to a better understanding of the complex interplay between sexual dysfunction and mental health.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Identifying Decision Making Parameters in Healthy Volunteers and Anxiety Patients

NCT05092971

Anxiety Healthy Volunteers

COMPLETED NA

Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders

NCT06661460

ANXIETY DISORDERS (or Anxiety and Phobic Neuroses) Specific Phobia Social Anxiety Disorder +4 more

NOT_YET_RECRUITING NA

Threat Reversal Abnormality in Patients With Anxiety Disorders

NCT06232369

Anxiety Disorder Anxiety State

NOT_YET_RECRUITING NA

Combined Treatment for Generalized Anxiety Disorder (GAD)

NCT00620776

Generalized Anxiety Disorder

COMPLETED PHASE2

Mechanisms of Treatment Change in Panic Disorder and Agoraphobia

NCT03547180

Panic Disorder With Agoraphobia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Premature Ejaculation Anxiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Training cohort

This cohort data will be used to screen for independent risk factors for anxiety disorders in patients with premature ejaculation and to initially construct a risk prediction model.

No interventions assigned to this group

Validation cohort

This cohort data will be used to verify the performance and stability of the risk prediction model to ensure the promotion and use of the model.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Comply with the international medical premature ejaculation diagnostic criteria
* Individuals with a "heterosexual" orientation who engage in vaginal intercourse
* Having a stable relationship with "monogamy"
* The International Index of Erectile Function-5 scale is ≥17 points, indicating that the patient has no erectile dysfunction or only mild erectile dysfunction
* Be informed of the purpose of this study, support this study, and complete the informed consent form

Exclusion Criteria

* Minors under the age of 18
* Individuals with a sexual orientation of "gay" or "bisexual"
* The judgment of "ejaculation too fast" is based only on masturbation or non-vaginal sexual intercourse
* The score of the premature ejaculation self-assessment scale is ≤8 points
* Suffering from diseases that may affect anxiety symptoms (hyperthyroidism/hypothyroidism, digestive diseases, malignant tumors, etc.)
* Within 2 months, have taken anti-anxiety drugs and/or drugs for PE treatment
* Those with a history of severe neurological diseases (such as epilepsy) and/or a history of schizophrenia, bipolar disorder, or other mental disorders
* Poor cooperation during diagnostic interviews

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No